The Lord Patel KT
Crossbench
Member of the House of Lords
M
Lord Patel's full title is The Lord Patel KT. His name is Narendra Babubhai Patel, and he is a current member of the House of Lords.
Allowance claims · 2026
Data not yet released for 2026 — the Lords Finance Office publishes monthly CSVs ~6-8 weeks after month-end.
Lords votes · 2026
176 divisions
20 Content(11.4%)
62 Not-Content(35.2%)
94 didn't vote(53.4%)
2026-07-13
Content
142–138
Content
2026-07-13
Not-Content
158–239
Not-Content
2026-04-13
Not-Content
135–154
Not-Content
2026-04-13
Not-Content
65–173
Not-Content
2026-03-26
Not-Content
64–140
Not-Content
2026-03-24
Not-Content
80–166
Not-Content
2026-02-04
Not-Content
62–295
Not-Content
2026-01-12
Not-Content
201–169
Content
2026-01-05
Not-Content
194–130
Content
2026-01-05
Not-Content
168–178
Not-Content
2026-01-05
Not-Content
210–131
Content
Source: lordsvotes-api.parliament.uk. "Result" shows the headline
Content vs Not-Content tally (including tellers). The Lords doesn't
publish a "didn't vote" attendance roll like the Commons, so the
figure above conflates absence with abstention.
Recent Hansard contributions · latest 25
2026-07-22
Healthcare Sector: Clinicians
My Lords, the Minister quite rightly alluded to the clinical entrepreneur programmes, and she might want to say a bit more about how successful they have been. Does she agree that, for these programmes to succeed in making clinical departments more innov
2026-07-09
Artificial Intelligence: Vaccine Technology
My Lords, the development of Evo 2—which is an AI biological model with 9.3 trillion nucleotides extending over 128,000 different species, including humans—means that there is now a capability to produce proteins, molecular structures and even genomes, a
My Lords, I thank the Minister for the Statement today and the noble Baroness, Lady Amos, for her excellent report. We have many reports now describing the tragedies occurring in maternity services. I hope this report will be the final one before we go b
2026-07-02
Higher Education: Affordability and Quality
My Lords, if the right reverend Prelate the Bishop of Leicester’s speech was inflammatory, mine is burned—so I am starting afresh, ad-libbing. I congratulate the noble Baroness, Lady Deech, on securing this debate. It is not an easy task to win a ballot
2026-06-24
Resistant Hypertension
My Lords, I will refine the previous questions. Resistant hypertension occurs when the blood pressure does not respond to standard treatment of two, three or even four drugs—hence we call it resistant hypertension. The reason why the renal system is invo
2026-06-23
Artificial Intelligence: Global Governance
My Lords, does the Minister agree that we are more likely to succeed in having international regulation for AI if the regulations are based not on a single set of regulations for all algorithms but on risk-based classifications in a set of regulations, a
2026-06-22
NHS: Dementia Treatment Trials
My Lords, if our intention is to increase the diagnosis rate of early dementia, normally what we would do is to find a screening test that would identify people at risk of any disease. There is one called Mini-Cog; it takes three minutes to administer an
2026-06-18
Prostate Cancer Screening: AI
My Lords, several trials are assessing the use of AI for prostate cancer screening and diagnostics, as well as testing the accuracy of digital imaging and histological imaging of biopsies to understand better the progression of disease. Some of them are
2026-06-16
Compassionate Use Medicine Schemes: VAT
My Lords, going back to the question about access to compassionate medicine, as I understand, the Minister just stated that medicines that are not yet authorised or licensed can be issued if companies agree to provide them for free, and that HMRC charges
2026-06-15
Rare Cancers: Diagnosis and Treatment
My Lords, we lead in genomic science and infrastructure by having established seven hubs for genomic testing. Despite this, we fall behind in testing for liquid biopsies of DNA and for circulating DNA, in histology testing, in molecular testing of cancer
I suggest that the Minister looks again at the evidence produced recently by Novo Nordisk, the manufacturer of Wegovy drugs for obesity reduction, to see whether what was just said still applies in the new study.
2026-06-02
Prostate Cancer Screening
My Lords, coming back to the Question from the noble Baroness, Lady Royall of Blaisdon, it is disappointing that the screening committee did not approve of screening for people with a strong family history, particularly of breast cancer, which the Minist
2026-06-01
Sovereign AI Fund
My Lords, I commend the Government for their sovereign AI development, particularly the Isambard-AI project at Bristol University, which has one of the world’s fastest processors. My question relates to parallel development. Do the Government still have
My Lords, the vaccine that exists is effective only against Ebola Zaire. The strain now operating has had two previous minor breakouts; Bundibugyo is the name of the strain. I hope the Minister will agree that our hope lies in developing a vaccine as qui
2026-05-20
King’s Speech
My Lords, I thank the noble Lord for that notice before I got up. In the brief few minutes I have, I am going to speak mostly about the Health Bill. The Bill is light in legislation, with 72 clauses and 48 pages, but it has 143 pages of schedules. One wo
2026-05-18
Miscarriage Care
My Lords, in an era of more personalised medicine, it is important to note that the care of women who have miscarried is dependent on several factors: the gestation age when miscarriage occurs, the age of the mother, and any existing diseases. It is not
2026-05-18
Healthy Life Expectancy: England
My Lords, healthy life expectancy is a mix of two data: a more precise life expectancy and a much cruder self-reporting of the stages of health. This leads to a confusing interpretation and therefore is not helpful in policy-making decisions. We have to
2026-04-28
UK Biobank Data
My Lords, I thank the Minister for his reply on the Statement, and I commend the Government for taking immediate action when this data breach was known. Last Tuesday, the Science and Technology Committee took evidence from the chief executive of UK Bioba
2026-04-23
Women’s Health Strategy
My Lords, my interests are well known in regard to women’s health. I congratulate the Minister on this report, which I think is a good one. The gaps are in how, in some places, it will be delivered on. But I also recognise her personal commitment to impr
2026-04-21
Cancer Outcomes in the UK
It is because of the speaker system.
2026-04-21
Cancer Outcomes in the UK
That the Grand Committee takes note of cancer outcomes in the UK and of plans to improve them including diagnostic care and research.
2026-04-21
Cancer Outcomes in the UK
My Lords, sitting on the same side as the Minister does not mean that I am on her side. I thank all noble Lords taking part in the debate and look forward to their contributions. There is a formidable array of talent, so the Minister should get a good re
2026-04-21
Cancer Outcomes in the UK
My Lords, I thank the Minister for her comprehensive response. She might reflect on some of the other points that she was not able to answer, such as the one on isotopes, which is very important. We have debated that before. One or two noble Lords quite
2026-04-21
Cancer Outcomes in the UK
Thank you. One in two people in the United Kingdom will develop cancer. Being born with cancer is rare, but a new cancer diagnosis is made every 75 seconds. The UK consistently ranks near the bottom of the table for survivals and deaths from cancers. Tha
2026-04-21
Cancer Outcomes in the UK
Can everyone hear me now? Can the noble Baroness, Lady Bottomley, hear?
Source: hansard.parliament.uk via hansard-api. Snippets shown
verbatim from the search API; click any debate title for the full record.
Register of Interests · 1 entries on file
Declarations under the Lords Code of Conduct. Free text — no monetary values, no hours worked. A declaration that an interest exists, not a claim about its size.
Nil
-
No registrable interests
registered 2025-04-07
Source: UK Parliament Members API (Lords register). Refreshed weekly.
Read the full
Lords Code of Conduct
for what each category covers and the disclosure thresholds.
Party history
1999-03-01 → present
Crossbench
current
Government posts
None recorded.
Opposition posts
None recorded.
Committee memberships
2026-01-27 → present
Science and Technology Committee
2017-06-27 → 2022-01-19
Science and Technology Committee
Chair
+£15,235/yr
2010-06-22 → 2015-03-30
Science and Technology Committee
1999-12-06 → 2008-11-26
Science and Technology Committee
2010-06-22 → 2011-09-13
Science and Technology: Sub-Committee I
2005-06-06 → 2006-11-08
Science and Technology: Sub-Committee I
2000-12-12 → 2003-11-20
Science and Technology: Sub-Committee I
2004-11-30 → 2005-04-07
Committee on the Assisted Dying for the terminally ill Bill
2012-05-16 → 2015-03-30
Procedure and Privileges Committee
2014-06-12 → 2015-02-11
Affordable Childcare
2015-06-11 → 2016-03-16
Social Mobility Committee
2016-05-25 → 2017-04-05
Long-Term Sustainability of the NHS Committee
Chair
+£15,025/yr
2024-01-24 → 2024-11-14
Preterm Birth Committee
Chair
+£17,806/yr
2025-10-14 → 2025-11-05
Terminally Ill Adults (End of Life) Bill Committee
Contact
Parliamentary office
patelnb@parliament.uk
020 7219 5353 · House of Lords, London, SW1A 0PW
020 7219 5353 · House of Lords, London, SW1A 0PW
APPGs (2026) · 3 active officership(s) · 7 historic
| Group | Role(s) | Funders | Officers in group | Next deadline |
|---|---|---|---|---|
|
All-Party Parliamentary Group for Longevity
Subject Group
|
Vice Chair | Collider Health | 7 | 2023-05-15 |
|
All-Party Parliamentary Group on Pancreatic Cancer
Subject Group
|
Vice Chair | Pancreatic Cancer UK | 7 | 2022-01-11 |
|
All-Party Parliamentary Group on Personalised Medicine
Subject Group
|
Vice Chair | PHG Foundation | 6 | 2021-05-29 |
One row per active APPG. Funder names link out via the
/appgs Top secretariat funders panel — click any funder
there to open its full relationship graph. Officer matching is name-based against
the parliament.uk register text and may miss titled / hyphenated variants.
Written parliamentary questions · 2026
No written questions tabled in 2026.
Bills sponsored & supported · 2026
0 bills
0 as lead sponsor
0 as supporter
No bills sponsored or supported in 2026.
Source: UK Parliament Bills API. "Lead" sponsor is the
primary mover (sortOrder = 1); "Supporter" rows are
members of either House who
backed the bill at introduction. Year is the bill's first-reading
date.
Historic bills (all-time)
0 bills
0 as lead sponsor
0 as supporter
No bills sponsored or supported on record.
Same source as the year-scoped panel above, but unconstrained by
year. The "Sponsored" tag = lead sponsor; "Supported" = backed at
introduction. Sorted newest first.